Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...

According to Business Research Insights the Cardiogenic Shock Treatment Market expected to exhibit a CAGR of 7% by 2032. The “Cardiogenic Shock Treatment Market” Research is your essential resource ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

we developed specific tools to help nurses and other clinicians know when to escalate a patient’s treatment to the shock pathway.” Educating the nursing team was one of the primary elements of the ...

The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

My name is Vakkaleri Nischitha Kumari and I am raising funds for my daughter, B.S Shanvika who is suffering from Refractory cardiogenic shock (RCS) and is undergoing treatment at Star Hospitals, ...

In this paper, we describe in detail our methodology for processing the MIMIC dataset as a part of developing a scoring system for predicting cardiogenic shock (CS) in patients suffering from acute ...

40 hours with a standard deviation of .37 hours. "Early recognition of patients with cardiogenic shock allows for prompt treatment initiation," the study authors wrote. "Timely intervention can ...

Sugar substitutes, substance abuse, GLP-1 drugs, and the biggest clinical trials of the year—each had their place in our top ...

An otherwise healthy woman in her 30s presented with cardiogenic shock and acute pulmonary oedema (APO), subsequently requiring extracorporeal ... They should not be used in isolation to guide ...